Swissmedic approves Roche drug Perjeta for patients with breast cancer
New personalised drug confers longer progression-free survival on patients with previously untreated HER2-positive metastatic breast cancer
Destruction of cancer cells through a trifunctional antibody
FDA expands Zytiga’s use for late-stage prostate cancer
Drug can now be used before treatment with chemotherapy
A new oral medication for the treatment of cystic fibrosis
First Drug to Extend Survival in Late-Stage Skin Cancer
Plenadren approved for treatment of Adrenal Insufficiency (AI)
ViroPharma Announces The First EU Market To Launch Plenadren® (Hydrocortisone, Modified-Release Tablet) For Treatment Of Adrenal Insufficiency, The First New Treatment Innovation For Over 50 Years
Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care
PRILOCAINE HYPERBAR SINTETICA in esclusiva per l'Italia
A partire dal 01 novembre 2008 Unipharma SA distribuirà in esclusiva in Italia il prodotto:
PRILOCAINE HYPERBAR SINTETICA 2% 10 fiale 5 ml
Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment...
Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment of HAE
Diventa fornitore unipharma
Diventa cliente unipharma
FDA Approves Kinrix - New Combination Vaccine for Children
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.
Acquisizione di Pharmion da parte di Celgene
Celgene Corporation ha comunicato in data 11 marzo 2008 il completamento dell'acquisizione, del valore di 2.9 miliardi di dollari, di Pharmion Corporation.